e-learning
resources
Glasgow 2004
Tuesday 07.09.2004
Non-CPAP therapy for OSA
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sleep apnoea syndrome is highly prevalent in pacemaker patients: a multicenter polysomnographic study in 98 patients
S. Garrigue, J. L. Pepin, P. Defaye, F. Murgatroyd, Y. Poezevara, J. Clementy, P. Levy (Pessac, Grenoble, Le Plessis Robinson, France; Cambridge, United Kingdom)
Source:
Annual Congress 2004 - Non-CPAP therapy for OSA
Session:
Non-CPAP therapy for OSA
Session type:
Oral Presentation
Number:
2993
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Garrigue, J. L. Pepin, P. Defaye, F. Murgatroyd, Y. Poezevara, J. Clementy, P. Levy (Pessac, Grenoble, Le Plessis Robinson, France; Cambridge, United Kingdom). Sleep apnoea syndrome is highly prevalent in pacemaker patients: a multicenter polysomnographic study in 98 patients. Eur Respir J 2004; 24: Suppl. 48, 2993
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Severe obstructive sleep apnea syndrome in elderly population: A prospective study of 80 patients
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies
Year: 2015
Acromegaly in sleep apnoea patients: a large observational study in 755 patients
Source: Eur Respir J 2016; 48: 1489-1492
Year: 2016
Obstructive sleep apnea syndrome in obese patients before bariatric surgery: A prospective observational study
Source: International Congress 2016 – Epidemiological aspects of obstructive sleep apnoea
Year: 2016
Clinical and polysomnographic differences in obstructive sleep apnea patients with different arousal threshold: a clinical study of 894 patients
Source: International Congress 2019 – Pathophysiological aspects of obstructive sleep apnoea from sea level to high altitude
Year: 2019
Comorbidities associated with sleep apnea - a nested case-control study in hospitalized patients
Source: Virtual Congress 2021 – Pathophysiology and clinical consequences of obstructive sleep apnoea
Year: 2021
Telemetrically triggered interventions in the first month of cpap treatment - A prospective, randomized controlled intervention trial in patients with a new diagnosis of obstructive sleep apnea syndrome
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016
Prevalence of obstructive sleep apnoea syndrome among patients of general hospital: epidemiological study
Source: Eur Respir J 2001; 18: Suppl. 33, 256s
Year: 2001
Treatment of central sleep apnea in patients with heart failure: A retrospective observational study
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012
Prevalence of restless legs syndrome among patients with obstructive sleep apnea before and after CPAP treatment, compared to the general population. The Icelandic Sleep Apnea Cohort (ISAC)
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012
Does CPAP therapy affect sleep time in patients with obstructive sleep apnea? A prospective study
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016
Outcome with CPAP in patients with suspected sleep apnea syndrome
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007
Cardiovascular, metabolic prognosis and mortality of the positional sleep apnea syndrome: An historical cohort study including 240 patients
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Sleep apnea syndrome in patients with stable chronic heart failure: Preliminary results of an Austrian pilot study
Source: Annual Congress 2010 - Sleep apnoea: insights from animal models and diagnostic tools
Year: 2010
Evaluation of a cardiorespiratory polygraphic device in patients with suspected sleep apnoea/hypopnoea syndrome (SAHS)
Source: Eur Respir J 2004; 24: Suppl. 48, 117s
Year: 2004
Elevated risk of motor vehicle accidents in patients with obstructive sleep apnea syndrome: A case-control study
Source: Annual Congress 2013 –Sleep disordered breathing in special situations II
Year: 2013
Mortality and morbidity in obstructive sleep apnoea–hypopnoea syndrome: results from a 30-year prospective cohort study
Source: ERJ Open Res, 6 (3) 00057-2020; 10.1183/23120541.00057-2020
Year: 2020
Symptoms of snoring and sleep apnea in women – a population-based study
Source: Annual Congress 2008 - Socioepidemiological studies in obstructive sleep apnoea
Year: 2008
Adaptive servoventilation (ASV) decreases unplanned hospitalisations in chronic heart failure (CHF) patients with central sleep apnoea (CSA): The French multicentre, prospective FACE cohort study
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015
CPAP trial in patients with significant sleep apnoea but few symptoms or mild sleep apnoea with marked symptoms – a retrospective audit
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007
Vasopressin in patients with obstructive sleep apnoea syndrome – An interventional, case-control study
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept